2026 is gearing up to be another milestone year in diabetes innovations. From continuous ketone monitoring to once-weekly insulin and new GLP-1 combinations like the “Triple G”, it should be an exciting year! Here are the biggest advancements coming down the pike.
read more →
Wayne was diagnosed in the “dark ages” of type 2 diabetes when there were only two treatment options available. His 40-year journey with T2D shows how staying curious and being proactive can turn an overwhelming diagnosis into a decades-long success story.
read more →
From stem cell and gene therapy advancements to expanded pump-sensor partnerships and new FDA medication approvals, this roundup hits the biggest diabetes breakthroughs in 2025.
read more →
If you’ve ever been told you need more medication, a higher dose of medication, or insulin, it’s not because you failed at managing type 2 diabetes. Learn about the natural progression of T2D, and how the latest treatment therapies can reduce the risk of serious complications.
read more →
Over the last two years, there’s been conflicting information in the news about GLP-1 medications and mental health. Some reports raised concerns about possible mood-related side effects, but others shared mental health benefits and broader therapeutic potential. Here’s what we know so far – and what still needs further research.
read more →
If You’re a Member of the Healthcare Community–You Can’t Miss Our Next CME!
Earn easy CME credits and improve patient outcomes—all at your own pace.
